ArticleDrug delivery and translational research2026
Multiprotein-based nanomedicines with dual CD44/CD133 targeting and GSH-responsive drug release for improving cancer chemotherapy.
Lu-Yi Yu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.